HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC fluoride treatment rinses, gels should carry poison warnings on labels -- FDA's Bowen.

This article was originally published in The Rose Sheet

Executive Summary

OTC FLUORIDE TREATMENT RINSES, GELS SHOULD CARRY POISON WARNINGS ON LABELS, FDA OTC Division Director Debra Bowen, MD, said in a June 14 letter to the Nonprescription Drug Manufacturers Association. Responding to a joint request from NDMA and the Cosmetic, Toiletry, and Fragrance Association for an exemption from the warnings for OTC fluoride-containing preventive treatment gels and treatment rinses, Bowen said the division "has determined that the first and second general warnings under Sec. 330.1(g) should be required in the labeling."
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS002998

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel